Shimamura Yuto, Ikeya Takashi, Marcon Norman, Mosko Jeffrey D
Division of Gastroenterology, St. Michael's Hospital, University of Toronto, Toronto, ON M5B1W8, Canada.
Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
World J Gastrointest Endosc. 2017 Sep 16;9(9):438-447. doi: 10.4253/wjge.v9.i9.438.
Esophageal cancer is one of the leading causes of cancer-related death and is associated with high morbidity and mortality. It carries a poor prognosis as more than half of patients present with advanced and unresectable disease. One contributing factor is the increased risk of lymph node metastases at early stages of disease. As such, it is essential to detect squamous cell neoplasia (SCN) at an early stage. In order to risk stratify lesions, endoscopists must be able to perform image enhanced endoscopy including magnification and Lugol's chromoendoscopy. The assessment of both the horizontal extent and depth of any lesion is also of utmost importance prior to treatment. Endoscopic mucosal resection and submucosal dissection remain the standard of care with literature supportive their respective use. Radiofrequency ablation and other endoscopic treatments are currently available although should not be considered first line at this time. Our objective is to review the current options for the endoscopic diagnosis and treatment of esophageal SCN.
食管癌是癌症相关死亡的主要原因之一,其发病率和死亡率都很高。由于超过一半的患者就诊时已处于晚期且无法切除,其预后较差。一个促成因素是疾病早期淋巴结转移风险增加。因此,早期检测鳞状上皮瘤变(SCN)至关重要。为了对病变进行风险分层,内镜医师必须能够进行包括放大内镜和卢戈氏染色内镜检查在内的图像增强内镜检查。在治疗前,评估任何病变的水平范围和深度也至关重要。内镜黏膜切除术和黏膜下剥离术仍然是标准的治疗方法,有文献支持各自的应用。目前虽然有射频消融和其他内镜治疗方法,但目前不应将其视为一线治疗方法。我们的目的是综述目前食管SCN的内镜诊断和治疗选择。